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Abstract
Background: Approximately 11,000 people die in Scotland each year as a result of smoking-related causes. Quitting
smoking is relatively easy; maintaining a quit attempt is a very difficult task with success rates for unaided quit attempts
stubbornly remaining in the single digits. Pharmaceutical treatment can improve these rates by lowering the overall
reward factor of nicotine. However, these and related nicotine replacement therapies do not operate on, or address,
the spatial and contextual aspects of smoking behaviour. With the ubiquity of smartphones that can log spatial,
quantitative and qualitative data related to smoking behaviour, there exists a person-centred clinical opportunity to
support smokers attempting to quit by first understanding their smoking behaviour and subsequently sending them
dynamic messages to encourage health behaviour change within a situational context.
Methods: We have built a smartphone app—MapMySmoke—that works on Android and iOS platforms. The
deployment of this app within a clinical National Health Service (NHS) setting has two distinct phases: (1) a 2-week
logging phase where pre-quit patients log all of their smoking and craving events; and (2) a post-quit phase where
users receive dynamic support messages and can continue to log craving events, and should they occur, relapse
events. Following the initial logging phase, patients consult with their general practitioner (GP) or healthcare provider
to review their smoking patterns and to outline a precise, individualised quit attempt plan. Our feasibility study consists
of assessment of an initial app version during and after use by eight patients recruited from an NHS Fife GP practice. In
addition to evaluation of the app as a potential smoking cessation aid, we have assessed the user experience,
technological requirements and security of the data flow.
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Results: In an initial feasibility study, we have deployed the app for a small number of patients within one GP practice
in NHS Fife. We recruited eight patients within one surgery, four of whom actively logged information about their
smoking behaviour. Initial feedback was very positive, and users indicated a willingness to log their craving and
smoking events. In addition, two out of three patients who completed follow-up interviews noted that the app helped
them reduce the number of cigarettes they smoked per day, while the third indicated that it had helped them quit.
The study highlighted the use of pushed notifications as a potential technology for maintaining quit attempts, and the
security of collection of data was audited. These initial results influenced the design of a planned second larger study,
comprised of 100 patients, the primary objectives of which are to use statistical modelling to identify times and places
of probable switches into smoking states, and to target these times with dynamic health behaviour messaging.
Conclusions: While the health benefits of quitting smoking are unequivocal, such behaviour change is very difficult to
achieve. Many factors are likely to contribute to maintaining smoking behaviour, yet the precise role of cues derived
from the spatial environment remains unclear. The rise of smartphones, therefore, allows clinicians the opportunity to
better understand the spatial aspects of smoking behaviour and affords them the opportunity to push targeted
individualised health support messages at vulnerable times and places.
Trial registration: ClinicalTrial.gov, NCT02932917.
Keywords: Smoking cessation, Smartphone, App, Hidden Markov models, INLA, Geospatial
Background
Approximately 11,000 people die each year in Scotland
as a result of smoking-related causes (statistics taken
from the Scottish Public Health Observatory, https://
scotpho.nhsnss.scot.nhs.uk/scotpho/homeAction.do, last
accessed 4 October 2016). Despite many therapies that
have been introduced over the years, maintaining a quit
attempt remains a monumentally difficult task, and most
people require several quit attempts before they success-
fully maintain cessation at 1 year. Unaided quit attempts
are successful only about 3–6% of the time [1]. Quit
attempts that are aided by cessation support and pharma-
ceutical treatment with nicotine replacement therapy are
more likely to be successful [1]. However, even the most
effective drug-related therapies, e.g. varenicline, only
increase success rate to approximately 24% [2]. Despite this
increase in success rate, varenicline and other interven-
tions do not operate on the role of the spatial or built
environment on smoking behaviour, i.e. certain cues in the
environment can still trigger the craving, even when the
drug is being taken. We know from clinical studies on rats
that spatial patterns can play a big role in nicotine-seeking
behaviour [3], and we know in humans that cue-induced
triggers play a big role in smoking behaviour [4]. In
addition to these issues, we are at a period in history where
more and more people carry sophisticated smartphones
with them at all times. These devices are capable of moni-
toring location, and possibly how mood changes with loca-
tion. Therefore, a research opportunity exists to investigate
the role that spatial context plays on three important
health behaviours: (1) individual smoking behaviour; (2)
maintaining smoking cessation; and (3) what might trigger
smoking relapse. Here, we highlight how we will conduct
this research within a clinical setting by using a mobile
phone app to help monitor smoking behaviour at specific
places and times, and to provide patients smartphone-
based support in their efforts to quit smoking.
The rise of mobile phones, and in particular smart-
phones, offers researchers and health practitioners a
unique opportunity to capture a more precise and indi-
vidualised picture of a patient’s smoking behaviour and
related emotions and cognitions through time and across
space. In theory, these longitudinal health profiles can be
used to better target intervention and to support smoking
cessation attempts by communicating to the patient at
times and places meaningful to the individual [5].
The use of mobile phones in clinical settings is an
emerging research thread and is being applied in a
variety of health systems including smoking [5]. A recent
Cochrane review [6] highlighted 12 studies using mobile
and smartphones in smoking cessation. These 12 studies
indicate a significant benefit of mobile phone-based
intervention, with a relative effect estimate of 1.67.
Specifically, mobile phone intervention increases rates of
cessation from 53 per 1000 to ~93 per 1000 [6]. Two
more recent studies have also shown (a) benefits of one-
way (provider to patient) social interchange [7] and (b)
effectiveness of social platforms, e.g. WhatsApp, that
accompany cessation studies [8].
Moving beyond smoking cessation, developers have
flooded the market with apps designed to help foster
wellness and health [9], yet the efficacy of many of these
apps remains unproven. For example, many apps log
‘health’ or wellness behaviour and provide generic advice,
but too often there is no documented record of clinical
significance of the app’s intervention [9]. While the
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technological developments have made this type of com-
munication easy, the community is still catching up to
determine the efficacy of such communication. In terms
of the delivery of these messages, it is unclear whether or
not the timing and location of the patient matters for
overall efficacy. Though it seems logical to harness the
power of smartphones and the data they collect, we are
unaware of apps that provide both individualised advice at
times and places that are meaningful. For example, most
of the smoking cessation studies rely on SMS-based mes-
saging, which while clearly successful [10], cannot easily
be tied to specific geographic locations. This is changing
though; the Q Sense app uses geofencing to provide
spatially explicit messaging [11]. Geofencing in this
context means that the phone’s GPS system establishes a
perimeter around a known location, e.g. ‘Home’. When
the user enters this location, each event can be tagged as
at home, and/or support messages specific to this location
can be triggered. In two additional studies, Reitzel et al.
[12] and Mitchell et al. [13] both marry ecological
momentary assessments (EMA) data with geospatial data.
Finally, while apps have flooded the market, relatively few
studies are supported and backed by health behaviour
change models [14].
Inspired by recent calls to examine the role of the
spatial environment in health behaviour [15], we have
built a mobile phone application (app), whose clinical
deployment is comprised of two distinct phases. In the
first phase, the patient logs their smoking behaviour and
craving events for 2 weeks. Following this logging phase,
the patient will meet with their health professional to
review their behaviour. The goals of this meeting will be
twofold: (1) to understand the specifics of the patient’s
smoking behaviour; to pinpoint, in time and space, the
critical cigarettes; and (2) to use motivational interview-
ing [16, 17] in order to outline a series of quit-related
goals and implementation intentions [18]. The app will
also capture spatial information connected with relapse
events, which may help inform the role the built envir-
onment plays in relapse behaviour. Here, we describe
the main functionality of the app, details of the feasibility
study, our data security protocol and proposed statistical
analysis of the data.
Methods
Aim, design and setting
We have received ethical approval from the National
Health Service to deploy this app with patients in a clin-
ical setting in two feasibility studies of increasing size
(approval granted 26 February 2016; REC Reference: 16/
WM/0068; IRAS Project ID: 191816). In this paper, we
report on the successful completion of the first of these
and the use of the initial results to aid the design of the
second feasibility study.
The design and setting for the initial feasibility study
was a maximum of 10 patients within one general prac-
tice surgery in Fife, UK; patients were recruited and
monitored by JM. We chose this small number of
patients from this practice so that we could quickly get
the app into the hands of actual smokers, and therefore
more quickly get feedback on the app. To recruit these
first 10 patients, we created and displayed a poster in
the practice. Also, JM reached out to individual patients
to notify them of the study and ask them if they would
be interested in participating. Patients who expressed
interest in participating were subsequently consented
with a different PI from JM.
The second study will involve up to 100 patients
recruited primarily through the NHS Fife Smoking
Cessation Services. Target patients for both studies are
active smokers interested in quitting, and in possession
of a smartphone with a data plan. By active, we mean
patients who regularly have one or more cigarettes per
week, and specifically that the patients inhale smoke
from burning tobacco encased in cigarettes, pipes or
cigars. We exclude patients with serious mental illness,
and those without a smartphone. The flow of patients
through the study is shown in Fig. 1.
Inclusion criteria
 Live or work in Fife, Scotland, UK
 Age 18 or greater
 Active smoker interested in quitting
 Possess an Android or iOS (at least iOS 7.0)
smartphone with a data plan
 Give informed consent
Exclusion criteria
 Serious mental illness
 Learning difficulty
Study details
The primary objective of the first small feasibility study
was to see if it is possible to deploy the MapMySmoke
app within a National Health Service (NHS) setting; that
is, we sought to take the app out of the development lab
and into the hands of actual patients. In so doing, we
wanted to test the underlying technologies and develop-
ment infrastructure, and to ensure that data is collected,
transmitted, stored and retrieved at suitable levels of
security of patient identifiable information. Second, we
sought feedback on whether patients find it an accept-
able aid. Third, we sought feedback on ways to improve
the app ahead of a second, larger, deployment.
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App database/data security
Each craving or smoking event logged by the user is sent
to a secure server stored within the University of St
Andrews School of Medicine. The data are transferred
from the phone to the server using Transport Layer
Security protocol and industry standard for e-commerce.
The data that are collected by the MapMySmoke app at
each craving or smoking event are stored on the server
after two layers of encryption. We use a double key
(private and public) system to store the data in a database,
with the outer layer protected by a 2048-bit private key
held by the project PI (GH). The data transfer is one-way,
i.e. from the phone to the server. Once the encrypted data
are on the server, there are two further restrictions regard-
ing use by co-principal investigators: (1) only anonymised
data are available; and (2) access to these anonymised data
is limited to secure access computer terminals within the
School of Medicine at the University of St Andrews.
Fig. 1 Schematic of patient progress through the MapMySmoke study
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Results
We consented eight patients in a surgery in Fife and
installed the first version of the MapMySmoke app on
their phones (Fig. 2). Of these eight, four patients logged
regularly (Table 1, Fig. 3). In addition, we obtained direct
feedback from three of the patient volunteers—two via
face-to-face follow-up interviews and one by phone
interview—all three patients completed at least 2 weeks
of logging. All three of these patients had been regular
smokers for >20 years. Feedback was very positive
(Table 2). In particular, patients reported that the act of
logging made them more aware and decreased smoking
and craving behaviour (Table 2). Two people commen-
ted that the logging process reduced the amount they
smoke, and one patient was able to quit smoking with
the aid of the app and NRT. Two commented that they
were surprised at how much they actually smoked
having looked at the visual feedback. One commented
that it was helpful seeing smoking behaviour; for him,
the time and place were helpful in highlighting his
smoking habits, which helped him work out a quit
smoking strategy. One patient liked receiving the pop-up
messages. Another particularly liked the heat map, i.e.
the spatial representation of smoking and craving behav-
iour. A few reported technical difficulties associated with
the installation—especially on older phones. Despite
repeated follow-up attempts, we did not obtain feedback
from all users. We suspect that some of them may have
felt guilty about not logging and/or attempting to quit,
so they did not report further feedback to the GP. In
terms of suggested improvements, one user suggested
adding a social component to the app, while another felt
the app was simplistic and could use a bit more depth
(Table 2). One user felt that they wanted a way to see
past comments they had entered. Finally, JM reported
that one user suggested implementing a daily or weekly
summary of logged smoking behaviour (n.b. this has
been implemented for the next version).
In terms of the original objectives of the study—deter-
mine if we could deploy the app with actual patients in a
clinical setting, enable secure logging and transmission
of private health information and obtain feedback from
patients—we were successful on all counts. While we
only had a small number of patients log for an extended
period of time, their data were all captured and stored
securely; they reported positive feedback after using the
app (Table 2) and suggested helpful improvements.
Though it was not a goal of the study, all three patients
reported that the app helped them reduce or cease their
smoking behaviour.
Discussion
The overarching goals of the MapMySmoke app study,
i.e. both the small feasibility study reported here, as well
Fig. 2 Screenshots from the MapMySmoke app indicating one data entry screen and two visual summaries
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as the larger pilot study, are myriad; the first two are
patient focused, while the second two are research
focused. First, we wish to facilitate a better understand-
ing of an individual patient’s smoking profile. Similar to
a food diary, the goal is to enable users to precisely
document where and when they had cigarettes and crav-
ing events, and to easily tag each event with quantitative
and qualitative metadata. Through the accumulation of
data over an initial 2-week logging phase, the app will
generate a detailed snapshot of the individual patient’s
smoking behaviour.
The second goal is to share these data with the GP or
healthcare provider, e.g. medical social worker, to gener-
ate an individualised plan to support each patient after
they start their quit attempt. The ways in which the app
will attempt to do that are as follows:
1. Highlight smoking patterns in time and across space
2. Identify critical cigarettes
3. Identify critical times for craving
4. Pair smoking behaviour with tailored, evidence-
based support messages
The third goal—a research goal—is to see if we can
identify optimal times and places to send the user
dynamic support messages. Ideally, these messages
would be sent to an individual’s phone ahead of a likely
craving event. As a patient’s craving increases, they are
more likely to want to smoke. This shift in desire could
be classified as an underlying change in motivational
state. That is, some combination of physiological status
and psychological triggers could lead to the individual
wanting to smoke (note that some of the physiological
Table 1 Data collected during the first feasibility trial. Of eight consented patients, four regularly logged. Scores shown are the
mean for each of five questions that accompany each smoking event (0–10 scale with 10 being higher, e.g. higher stress ahead of
the cigarette and higher craving level)
User No. of cigarettes Mean stress score Mean craving score Mean taste score Mean satisfaction score Mean craving reduction
User 1 14 0.75 5.46 5.57 5.96 5.25
User 2 90 5 4.94 5.08 5.05 5.11
User 3 62 3.775 6.59 3.89 6.29 4.68
User 4 4 4.75 6.25 5 7.37 5.25
Fig. 3 Map showing smoking locations as logged by two users in the first feasibility study. The colours indicate the smoker but have been
randomised to preserve anonymity. Size of the circle corresponds to the degree of satisfaction the patient expressed for each smoking event
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and psychological aspects can be aided with NRT and/or
varenicline; these are routinely offered to patients within
NHS Fife and will be offered to any patient participating
in the study). One way to quantify the changing prob-
ability of shifting into such a smoking state is to fit
hidden Markov models to the data logged during the
first 2 weeks. If we can quantitatively identify times and
places of these shifts, then we can better time the deliv-
ery of in-app support messages to the patient. That way,
the user can receive a support message when it is most
needed by him/her, as opposed to a generic message
delivered at the same time each day for every patient.
For example, based on their recorded smoking pattern,
patient A might be vulnerable to relapse at 3 pm while
they are at work, while patient B might be vulnerable to
relapse at 1 pm following lunch, etc. If each patient can
receive a tailored message in advance of their unique
craving event, then we would expect a priori that the
intervention would be more relevant. Research has
shown that prospective patients are more interested in
receiving tailored messages [19].
The fourth goal is to capture the spatial aspects of
relapse. This is accomplished simply by tying the logging
of a smoking event to the individual’s quit date. The quit
date is set at the patient-GP meeting and stored within
the app. Should a user log a smoking event after that
date, then that first event is stored as a relapse event.
We aim to understand the links between the spatial
environment and relapse behaviour through investigation
of the data associated with post-quit smoking events. In
addition to capturing spatial information associated with
the relapse, the app will send different messages to the
user after a relapse event. Essentially, the structure of the
app remains unchanged during this phase, but the context
of a smoking event entered post-quit will automatically be
tagged as a relapse event. Because this is a different type
of event, the next version of the MapMySmoke app will
provide the patient with dynamic messages designed to
support the user and encourage them to return to the quit
attempt. In summary, this goal is both not only research
related—in the sense that we will record the spatial
aspects of relapse—but also patient focused through the
relapse-related messaging.
The results from the feasibility study clearly show that
this app can be successfully deployed. Though we cau-
tion that it was a very small study limited to one GP
practice, we found that patients were comfortable using
the app, were able to better understand their smoking
behaviour via logging and reported liking the visual feed-
back from the app. This means that we can use these
results and patient-derived feedback (Table 2) to im-
prove the app and test its efficacy on a larger scale. In
the larger feasibility study, we will assess efficacy by
examining self-reported abstinence rates at 4 weeks, and
3 months following the quit date, and comparing them
to baseline data collected by NHS Fife. We chose these
dates because they are the dates used by NHS Fife’s
Tobacco Cessation Services team, which are in turn
following Scottish Government targets.
We will use the corpus of smoking data in at least four
unique ways. First, we will use data obtained during the
logging phase in an effort to quantify the probability of a
user switching into a smoking state. This is of interest
from a clinical standpoint, as it helps uncover the myriad
determinants of smoking behaviour. Our intention is to
use these state-switching probabilities in order to better
target support messages to individual patients. To do
this, we will use latent-state models in an effort to
understand the temporal distribution of smoking behav-
iour [20]. In later versions of the app, we intend to use
Fig. 4 Data flow for the MapMySmoke app
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these state-switching probabilities as the mechanism for
generating targeted ‘just-in-time’ support messages [5] to
the patient. Second, we will analyse data obtained during
the post-quit phase to quantify if the app-based inter-
vention increases rates of smoking cessation. Third, we
will try and fit marked point-process models [21] to the
spatial information data recorded at each event. These will
be used to better understand the spatial aspects of smok-
ing and craving events across individuals by accounting
for the spatial structure inherent in the data. We will also
explore fitting temporal marked point-process models to
the post-quit data to see if craving maps change over time.
Fourth, because the patient records their rate of smoking
the first time they encounter the app, we can quantify
adherence to using the app by comparing observed smok-
ing rates during the logging phase with those entered by
the user at the start of the intervention.
As the project has progressed, we have considered sev-
eral ways to improve the app. In the apps’ current form,
the data encryption and storage scheme does not allow
communication from the server back to the phone or to
the healthcare provider. Therefore, summary statistics and
maps of spatial smoking and craving behaviour are limited
to in-app display (Fig. 2). However, in future versions of
the schema (Fig. 4), we will offer patients and healthcare
providers the ability to receive statistical summaries of the
individual behaviour (Fig. 3). This could include initial
snapshots of likely behaviour at certain times and places.
This may be of great advantage to the GP/healthcare pro-
vider in that it could offer them a better understanding of
patient behaviour prior to the post-logging interview
thereby improving healthcare delivery at the point of care.
In addition, the app could be structured to deliver sup-
port to the users at vulnerable times and places. These
times and places are unique to each individual, and
based on their profiles generated during the logging
phase. Prior to implementing this feature, the sampling
and communication protocol within the app would be
subject to ethical approval within the NHS. While more
app-patient interaction and communication is likely to
be helpful [19], this must be balanced against data secur-
ity and privacy concerns [22, 23]. As more lines of com-
munication are made available, data are increasingly
vulnerable. In addition, research suggests that the effi-
cacy of sensing must be shown to be reliable and
effective before users would be open to the triggering of
context-based interventions [19].
Another feature we would like to address in the future
is the inclusion of social support with peers. Cheung
et al. [8] showed that the inclusion of a social sharing
platform (WhatsApp) resulted in fewer relapse events.
While the inclusion of such a social feature within Map-
MySmoke may raise further data security concerns, its
possible clinical benefits are worth exploring [19].
In early pre-release versions of the app, we imple-
mented a random forest algorithm [24] to deliver sup-
port messages. However, users reported anecdotally that
this was reminding them too much about their smoking
habit. For example, one user reported that the random
forest algorithm was learning that he liked to smoke at
home. One day as he walked home, he got a message
alerting him to the increased probability of smoking—even
though he himself was not craving a cigarette. Thus, the
app inadvertently triggered a craving event. Therefore, we
need to be careful that increased monitoring and usage of
the app has its intended effect—namely aiding smoking
cessation—and guard against the triggering or delivery of
unwanted smoking cues [19, 22].
Finally, in the first feasibility study, we encountered
several candidate patients with older phones that did not
support the current version of the MapMySmoke app.
This is because we are developing and deploying at the
leading edge of mobile technology. However, the remit
of the NHS Tobacco Support Services is aimed at popu-
lations with higher indices of deprivation. We propose
to address this issue of device incompatibility in future
versions by developing more backwards compatible ver-
sions. While this comes with some added development
cost, it opens up the study to more potential users and
builds-in equity of health promotion.
Conclusions
Since more and more humans have and use smart-
phones, there exists a clear opportunity to harness these
tools in the delivery of targeted, specific medical infor-
mation and support. In particular, we feel there is an
opportunity to (a) learn about individual smoking pat-
terns across space and through time and (b) use that
information to provide better, more tailored support
messages that aid and support a quit attempt. To
address this, we have built and successfully deployed a
mobile app designed to log individual smoker’s behav-
iour, provide graphical and statistical summaries of
smoking behaviour and support a quit attempt with the
delivery of in-app messages designed to provide specific
and time-relevant information to the smoker. Initial
feedback from users in the first feasibility study was very
positive. Thus, the MapMySmoke app could provide
practitioners with a new effective tool that supports
patients through the difficult process of quitting smok-
ing and maintaining abstinence from smoking.
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